Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Terminated 2

Sponsor Class

OTHER 141INDUSTRY 60NETWORK 10NIH 9FED 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 1Liver Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Capecitabine 2leucoselect phytosome 1gallium 68 PSMA-11 1Oxaliplatin 1Midazolam 1Ketamine 1Injections 1Immunoglobulins 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × FED × Capecitabine × Clear all
NCT00216424 2007-11-12

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

James A. Haley Veterans Administration Hospital

Phase 4 Terminated
40 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00216437 2007-11-12

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

James A. Haley Veterans Administration Hospital

Phase 1 Terminated
30 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡